Skip to main content

Published locations for AD outcomes improved with lebrikizumab and topical steroids

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. AD outcomes improved with lebrikizumab and topical steroids

User login

  • Reset your password
  • /content/ad-outcomes-improved-lebrikizumab-and-topical-steroids
  • /clinicianreviews/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical
  • /edermatologynews/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical
  • /familypracticenews/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical
  • /internalmedicinenews/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical
  • /pediatricnews/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical
  • /pediatrics/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical-steroids
  • /internalmedicine/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical
  • /dermatology/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical-steroids
  • /familymedicine/article/260655/atopic-dermatitis/ad-outcomes-improved-lebrikizumab-and-topical